DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/15919995
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15919995
CMK is pyrrolopyrimidine derivatives that contained a chloromethyl ketone designed by the University of California. CMK shows potent irreversible inhibition of RSK2 protein kinase in mammalian cells.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P51812 Gene ID: 6197.0 Gene Symbol: RPS6KA3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/15919995 |
|||
Target ID: CHEMBL1841 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15919995 |
4.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://google.com/patents/WO2005000197A2
Cmk were tested against the Src-family kinase Fyn, which has a threonine gatekeeper, which in principle should recognize the C-5 aromatic substituent of our inhibitors. At a concentration of 30 nM, cmk had no effect on wild-type (WT) Fyn, whereas it rapidly inactivated an engineered Fyn construct containing a cysteine in place of Val285. In the presence of 1 mM ATP, WT Fyn was relatively resistant to cmk, with IC50 values of 18 mM, respectively. In contrast, 100 nM cmk inactivated Val285Cys Fyn in less than 5 min under these conditions.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
P30085
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY | |||
|
EC 2.7.4.14
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY | |||
|
I9BC9TJN0M
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY | |||
|
CMPK
Created by
admin on Tue Apr 01 21:23:36 GMT 2025 , Edited by admin on Tue Apr 01 21:23:36 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD